| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |